A Phase II study of a GlaxoSmithKline drug to treat the blood cancer multiple myeloma has been successful, the company said Friday. The London-based...
News
Dual CAR T-cell combination a ‘promising treatment option’ for multiple myeloma
A combination of humanized anti-CD19 and anti-B-cell maturation antigen chimeric antigen receptor T-cells has shown activity in patients with...
Government urged to expand Pharmac’s drug budget after barrage of emotional pleas from sufferers
This story was originally published on Stuff "Why does New Zealand need to reinvent the wheel?" Posed by National MP Maggie Barry, that was the...
Health Select Committee hears pleas from survivors and sufferers
This story was originally published on RNZ Politicians heard emotional pleas today from cancer survivors, people with disabilities and health...
Blood cancer patient advocacy group presents to Health Select Committee to fund life-extending treatments
Dr Ken Romeril, chief executive, Myeloma New Zealand, is appearing today before the Health Select Committee in support of their submission asking...
Dr. Nadeem on Individualizing Therapy in Multiple Myeloma
Omar Nadeem, MD, a physician at Dana-Farber Cancer Institute and an instructor in medicine at Harvard Medical School, discusses individualizing...
Improved Clinical Outcomes in Relapsed/Refractory Multiple Myeloma With Daratumumab Re-Treatment
This story was originally published on the Hematology Advisor The introduction of monoclonal antibodies and immunomodulators into earlier lines of...
New medicine for multiple myeloma shows promising results
A new drug reduced the risk of relapse and increased survival by five months, according to a recent study. The results were presented at a cancer...
Innovation Fuels Survival Gains in Multiple Myeloma
In the past 20 years, we’ve been very fortunate in the development of effective myeloma therapies and have seen remarkable progress for our...
Daratumumab cuts risk for progression in multiple myeloma
For patients with newly diagnosed multiple myeloma, the addition of daratumumab to lenalidomide and dexamethasone is associated with a reduced risk...
Guyon Espiner investigates Pharmac: The NZ Buyer’s Club
Guyon Espiner reveals how lung cancer patients are buying cut-price drugs from India, as other New Zealanders fundraise, petition and apply for...
Early Treatment for Smoldering Multiple Myeloma
Smoldering multiple myeloma (SMM) is an asymptomatic clonal plasma cell disorder and is described as an intermediate stage between monoclonal...